Investor · 15 deals
Every published round Possible Ventures took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
Companies Possible Ventures has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Aquila | Jun 2023, Seed | 1 | 0 | |
| Buildxact | 1 Feb 2022, Series A | 1 | 0 | |
| Eden Brew | 4 Oct 2023, Series A | 1 | 0 | |
| Heidi Health | 25 Oct 2023, Series A | 2 | 0 | |
| Immutable | 8 Mar 2022, Series C | 2 | 0 | |
| Kite Magnetics | 5 Oct 2022, Seed | 1 | 0 | |
| Number 8 Bio | 15 Jun 2023, Pre-seed | 1 | 0 | |
| OwnHome | 22 Jul 2021, Seed | 2 | 0 | |
| Psylo | 1 Oct 2021 | 1 | 1 | |
| Sumday | Mar 2023, Pre-seed | 2 | 0 | |
| Uluu | 28 Nov 2022, Seed | 1 | 0 |
Fund closes reported for Possible Ventures, as distinct from the investments it has made.
Companies Possible Ventures has backed that another company then bought. An exit for the holding, not a deal Possible Ventures did.
| Name | Role | Sources |
|---|---|---|
| Chris Hitchen | Managing Partner · Founder | Startup Daily (Thu 27 Oct 2022), Startup Daily (Wed 2 Feb 2022), iTnews, buildxact.com, Startup Daily (Fri 1 Oct 2021) |
Stories naming Possible Ventures. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Heidi Health, whose AI tool drafts doctors' clinical notes, has added $26.8 million to its Series A in a round led by Headline, with Local Globe and Anthology also taking part.
Also SmartCompany·SmartCompany·SmartCompany·SmartCompany·Startup Daily·SmartCompany·Startup Daily·Startup Daily
Weekly roundup of eight Australian funding rounds, led by Samsara Eco's $100m Series A extension; Diraq, 1Breadcrumb, Aquila, NRN, Klean, Bearhug and Sindy Labs also secured capital, and Klean won a Queensland grant.
Also TechCrunch Venture·SmartCompany·@AuManufacturing·Techboard·Startup Daily·Startup Daily·SmartCompany·Startup Daily·SmartCompany·Startup Daily·@AuManufacturing·@AuManufacturing·Forbes Australia·@AuManufacturing
OwnHome has secured a $31 million Series A, with Square Peg Capital leading and Commonwealth Bank joining, as returning backers double down on its low-deposit route into home ownership.
Roundup of ten Australian startup raises totalling $38.8 million, topped by Heidi Health's Series A, also recording an Outstaffer executive appointment and the earlier sale of CarAdvice to Nine.
Heidi Health, whose AI tool trims paperwork for family doctors, has banked a $10 million Series A round led by returning backer Blackbird, with co-investors including Hostplus and Hesta.
Also Startup Daily·SmartCompany·Startup Daily·SmartCompany·Startup Daily·Forbes Australia·Forbes Australia
Melbourne healthtech firm Heidi Health has pulled in A$10 million Series A capital, headed by Blackbird Ventures, to grow its AI scribe that lightens clinicians' documentation workload.
Also SmartCompany·Startup Daily·SmartCompany·SmartCompany·SmartCompany·Startup Daily·SmartCompany·SmartCompany·SmartCompany·Startup Daily·SmartCompany·Startup Daily·SmartCompany
Roundup of four Australian raises in early October 2023: Eden Brew's $24.4m Series A, Renewable Metals' $8m seed round, Techni Ice's $979,774 crowd-funded campaign close, and Apollo Secure's $600,000 pre-seed.
Also Startup Daily
Precision fermentation company Eden Brew raised a $24.4 million Series A led by Main Sequence, with Breakthrough Victoria and other backers, to commercialise animal-free dairy and relocate from Sydney to Melbourne.
Also @AuManufacturing·SmartCompany·Startup Daily·Startup Daily·Startup Daily·AgFunderNews·AgFunderNews·Crunchbase News
Weekly roundup of six Australian startup raises: Lyka's Series B extension, plus new funding for HydGene, JDoodle, One Future Football, Aquila and Number 8 Bio, with investors and founder comment.
Also RenewEconomy·Startup Daily·SmartCompany·Startup Daily·SmartCompany·RenewEconomy·RenewEconomy
Weekly agrifoodtech digest: several venture raises including Uncommon's Series A, Bunge's agreed Viterra purchase, FreshRealm taking over Blue Apron, Nextbite sold, Meatless Farm ceasing trade, and American label approvals for cultivated chicken.
Also TechCrunch Venture
A biotech startup making a methane-cutting cattle feed additive has raised pre-seed capital from four backers, with the piece also recalling recent emissions-focused raises by two other Perth ventures.
Also AgFunderNews·AgFunderNews·SmartCompany·SmartCompany·AgFunderNews
Weekly agrifoodtech roundup reporting numerous startup funding rounds, fund closes by S2G Ventures and Bidra Innovation Ventures, and collapses including Upward Farms, Boxed, Kalera and Australia's CoLab.
Australian algae-based ingredients startup Provectus Algae has secured a strategic investment from CJ Bio to expand its carbon-negative biomanufacturing platform, with an interview covering its technology and plans.
Sydney psychedelic biotech Psylo has banked a $5 million seed round led by CSIRO's Main Sequence Ventures, its second raise since emerging from Startmate, to advance a fast-acting psilocybin therapy toward clinical trials.
Buildxact has completed an oversubscribed $18.5 million Series A, with Shearwater Capital among the backers and Regal Funds Management leading; several other investors also joined.
Sydney NFT gaming firm Immutable raised a $280 million Series C valuing it at $3.5 billion, led by Temasek with Tencent and Animoca Brands, six months after an $82 million raise.
Also SmartCompany·SmartCompany·Techboard·SmartCompany·SmartCompany·SmartCompany·SmartCompany·Startup Daily·Startup Daily·Forbes Australia·Forbes Australia·Crunchbase News
AfterWork Ventures explains why it joined OwnHome's July pre-seed round, profiling the rent-to-buy startup's founders, its debt facility, customer traction, and the housing affordability problem it tackles.
Sydney psychedelic biotech Psylo has raised $1.1 million in a round led by Possible Ventures, with angel Daniel Petre also backing it, to develop shorter-acting psilocybin-inspired mental health medicines.